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Marine sponges have been recognized as potentially rich sources of various bioactive molecules. In our continuing search for new
secondary metabolites from Indonesian marine invertebrates, we collected a sponge, whose extract showed cytotoxicity against
cultured cells at 0.1μg/mL. Puriﬁcation of the extract yielded two new macrolides 2 and 3 along with known candidaspongiolide
(1). The structures for compounds 2 and 3 were elucidated by spectral analysis (1H, 13C, COSY, HMQC, HMBC) and by
comparison of their NMR data with those of 1. Compounds 2 and 3 exhibited a little more potent cytotoxicity (IC50 4.7 and
19ng/mL) than that (IC50 37ng/mL) of candidaspongiolide (1) against NBT-T2 cells.
1.Introduction
Sponges, a group of sedentary organisms, cannot move
and escape from predators. Most sponges are ﬁlter feeders
pumping water to its body to obtain foods and oxygen and
to expel wastes and may be threatened by microorganisms
during ﬁltering seawater rich in bacteria and fungi [1, 2].
In order to defend themselves against predators, pathogens
and competitors, sponges may have developed to produce or
accumulate secondary metabolites during their long evolu-
tion,suchasfeedingdeterrent,antimicrobial,antifungal,and
antifouling molecules. Interestingly, some of the compounds
have also shown remarkable potency as drug candidates
against various human diseases as discussed elsewhere [3–9].
In 1984, Schmitz and coworkers isolated tedanolide from
the Caribbean marine sponge Tedania ignis [10]. Tedanolide
is a unique 18-membered macrolide where lactonization
occurs at a primary hydroxyl group instead of a common
secondary one, and this class of macrolide has been reported
to exhibit strong cytotoxicity atpico to nanomolar range [10,
11]. The unique structure in combination with promising
biological activity leads tedanolide as an intriguing target
for formal and total syntheses [12–14]. More recently,
Meragelman and coworkers reported a macrolide named
candidaspongiolide (1) related to tedanolide with modiﬁca-
tionatC-11toC-15fromthemarinespongeCandidaspongia
sp. Candidaspongiolide exhibited potent cytotoxicity in NCI
60 cells panel with GI50 of 14ng/mL [15], protein synthesis
inhibition, and apoptosis induction [16].
In our continuing search for potential drug leads from
Indonesian marine invertebrates [17, 18], we obtained a
sponge whose extract showed cytotoxicity at 0.1μg/mL
against NBT-T2 cells in a screening process. Puriﬁcation of
the extract provided candidaspongiolide (1) along with two
new analogs 2 and 3, which are the subject of this paper.
2.MaterialsandMethods
2.1. Chemicals and Equipments. Methanol (MeOH) used for
extraction was of technical grade. Reagent grade solvents
were used for isolating compounds 1–3. Merck Si-60 (70–
230mesh) was used for silica gel column chromatography,
while Merck Si-60 F254 for analytical TLC. HPLC was
performed either on a Waters 510 pump with a Waters
486UV detector and a Shodex RI-101 or on a Hitachi
L-6000 pump with a Hitachi L-4000UV detector and a
Shodex RI-101 using a Mightysil Si-60 (10 × 250mm)2 ISRN Pharmaceutics
column. Optical rotations were measured on a Jasco P-
1010 polarimeter using a cell with 3.5mm aperture. IR
spectra were recorded on a Jasco FT/IR-6100 instrument,
whereas HRESIMS was measured on a Jeol JMS-T100LP
spectrometer using reserpine or sodium triﬂuoroacetate as
an internal standard. Most of 1Ha n d13C NMR spectra
were measured in CDCl3, while those of compound 3 were
measured in CD3OD with TMS as an internal standard on
a Jeol A500 and/or a Bruker AVANCE III-500 in CDCl3.T h e
1Hand13Cchemicalshiftsweregiveninppm,whilecoupling
constants were inHz.
2.2. Sponge. Specimens of the sponge tagged K09-02 was
collectedbyhandusingSCUBAat15–25mdepthatKupang,
West Timor, East Nusa Tenggara, Indonesia on August 2009.
By comparing underwater images of our specimen with that
of the specimen of NCI group [15], it is likely to be the same
sponge. The specimen was kept frozen until extraction. The
spongeK09-02maybeanendemicspeciestothisregion.The
colonies are grey in color and stand.
2.3. Extraction and Isolation. After cutting into small pieces,
the sponge (653g, wet) was soaked in MeOH for 24h for
three times. Then, the solution was concentrated under
vacuum to obtain a crude extract. The methanolic extract
(17.0g) was triturated with ethyl acetate (EtOAc) to provide
a lipophilic fraction (2.7g), which killed NBT-T2 cells at
0.1μg/mL. This fraction was subjected to a silica gel column
eluting with stepwise gradient solvents (hexane:EtOAc =
2:1, 1:1, 1:2, 0:1, EtO Ac:MeOH = 10:1) to aﬀord ten
fractions. Fraction 5 (126.0mg) was puriﬁed by repeti-
tive Si-60 HPLC using hexane-EtOAc mixtures to provide
candidaspongiolide 1 (15.4mg). Fraction 6 (70.8mg) was
also puriﬁed by Si-60 HPLC using a solvent system hex-
ane:EtOAc = 2:1toaﬀord compound 2(9.8mg). Fraction 9
(107.1mg) was also subjected to repetitive Si-60 HPLC using
hexane:EtOAc = 1:6,EtO Ac:CH 2Cl2 :MeOH = 20:20:1,
and EtOAc:CH2Cl2 :MeOH = 10:20:1 as solvent systems
sequentially,togivecompound3(21.8mg).Isolationofthese
compounds was guided by cytotoxicity testing and NMR
spectra.
2.4. Compound 1. Colorless glass, [α]
25
D +69 (c 0.55, MeOH).
IR νmax (neat) 3419, 2925, 2854, 1742, 1715, 1456, 1372,
1234, 1086cm−1. 1Ha n d13C NMR; see Tables 1 and 2.
HR-ESIMS [M+Na]+ m/z 945.55514, 959.57079, 973.58884
(calcd for C50H82NaO15
+ 945.55459 (Δ +0.58ppm),
C51H84NaO15
+ 959.57024 (+0.57ppm), and C52H86NaO15
+
973.58589 (+3.0ppm)).
2.5. Compound 2. Colorless glass, [α]
25
D +72 (c 0.75, MeOH).
IR νmax (neat) 3421, 2925, 2854, 1748, 1715, 1456cm−1. 1H
and 13CN M R ;s e eT a b l e s1 and 2. HR-ESIMS [M+Na]+ m/z
903.54964, 917.56023, 931.57576, 945.60036 and 959.61056
(calcd for C48H80NaO14
+ 903.54403 (Δ +6.2ppm),
C49H82NaO14
+ 917.55968 (+0.60ppm), C50H84NaO14
+
931.57533 (+0.46ppm), C51H86NaO14
+ 945.59098 (+9.9
ppm), and C52H88NaO14
+ 959.60663 (+4.1ppm)).
2.6. Compound 3. Yellow glass, [α]
25
D +97 (c 0.35, MeOH).
IR νmax (neat) 3418, 2925, 2854, 1715, 1457, 1373, 1244,
1084, 995cm−1. 1Ha n d13CN M R ;s e eT a b l e s1 and 2.H R -
ESIMS [M+Na]+ m/z 665.31522 (calcd for C32H50NaO13
+
665.31436 (+1.3ppm)).
2.7. Acetylation. Compound 1 (0.2mg) was dissolved in
pyridine (50μL) and acetic anhydride (50μL). The mixture
was stirred for three days under a nitrogen atmosphere at
room temperature. After removal of excess reagents with
nitrogen ﬂow and vacuum, the reaction product 4 was
checked with 1H NMR and ESIMS. Compound 2 was
similarly treated to give 4.
2.8. Compound 4 from 1. 1HN M R :δ5.65dd (J = 2.7,
9 . 5 H z ) ,5 . 5 2 m ,5 . 5 1 d( J = 10.1Hz), 5.36m, 5.34dd (J =
2.2, 9.1Hz), 5.28dt (J = 2.3, 10.5Hz), 5.07d (J = 11.0Hz),
4.79d (J = 6.6Hz), 4.54dd (J = 2.0, 11.3Hz), 4.25dd
(J = 2.3, 8.1Hz), 4.13dd (J = 6.3, 11.5Hz), 3.43s (3H),
3.34dq (J = 10.0, 6.7Hz), 3.29dq (J = 10.5, 7.0Hz), 3.01dd
(J = 9.2, 18.4Hz), 2.88d (J = 9.3Hz), 2.60dd (J = 2.6,
18.4Hz), 2.35–2.4m, 2.32dd (J = 1.9, 9.3Hz), 2.21s (3H),
2.10s (3H), 2.09s (3H), 2.02s (3H), 1.69d (J = 1.1Hz,
3H), 1.66dd (J = 1.7, 6.8Hz, 3H), 1.44d (J = 7.1Hz, 3H),
1.37s (3H), 1.17d (J = 7.1Hz, 3H), 1.08d (J = 6.6Hz,
3H), 0.90t (J = 6.1Hz, 3H). HR-ESIMS m/z 1072.60225,
1086.60997, 1099.62465 (calcd for 12C55
13CH88NaO18
+
1072.59019 (+11.24ppm), 12C56
13CH90NaO18
+ 1086.60584
(+3.8ppm), and C58H92NaO18
+ 1099.61814 (+5.9ppm)).
2.9. Compound 4 from 2. 1HN M R :δ 5.65dd (J = 2.6,
9.8Hz), 5.52m, 5.51 d (J = 10.2Hz), 5.37m, 5.34dd (J =
1.7, 9.1Hz), 5.28dt (J = 1.7, 10.5Hz), 5.07 d (J = 10.9Hz),
4.78d (J = 6.3Hz), 4.54dd (J = 3.1, 11.7Hz), 4.25dd (J =
2.3, 8.1Hz), 4.13dd (J = 6.5, 11.3Hz), 3.43s (3H), 3.34dq (J
= 10.1, 5.7Hz), 3.29dq (J = 10.5, 7.2Hz), 3.01dd (J = 9.4,
18.6Hz), 2.88d (J = 9.2Hz), 2.60dd (J = 2.5, 18.6Hz), 2.35–
2.4m, 2.32 (J = 1.9, 9.3Hz), 2.22s (3H), 2.10s (3H), 2.09s
(3H), 2.02s (3H), 1.70d (J = 1.1Hz, 3H), 1.62dd (J = 1.7,
6.8Hz, 3H), 1.44d (J = 7.1Hz, 3H), 1.37s (3H), 1.17d (J
= 7.1Hz, 3H), 1.08d (J = 6.6Hz, 3H), 0.90t (J = 6.1Hz,
3H). HR-ESIMS [M+Na+] m/z 1071.58258, 1085.60199,
1099.61165 (calcd for C56H88NaO18
+ 1071.58629 (−4ppm),
C57H90NaO18
+ 1085.60194 (−.5ppm), and C58H92NaO18
+
1099.61759 (−5.9ppm)).
2.10. Screening Process. NBT-T2 cells were purchased from
Riken and used for cytotoxicity testing. NBT-T2 is a cell
line derived from chemically induced rat bladder carcinoma
cells [19] .T h es p o n g ee x t r a c tw a st e s t e da t0 . 1 ,1 ,a n d
10μg/mL in triplicate, while fractions were done at 0.01,
0.1, and 1μg/mL. The cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
Sigma antibiotic-antimycotic, Biowest fetal bovine serum,
Gibco MEM nonessential amino acid in a Falcon 24-well
plate or 48-well plate. After adding the extract or a fraction,
cells were incubated for 24h under 5% CO2 at 36◦C[ 16].ISRN Pharmaceutics 3
Table 1: 13C NMR data for compounds 1, 2,a n d3.
Cn o . 115,a 1a 2a 3b
1 171.3 qC 171.3 qC 171.3 qC 171.3 qC
2 70.7 CH 70.8 CH 70.8 CH 72.9 CH
3 83.4 CH 83.3 CH 83.1 CH 84.7 CH
4 47.8 CH 47.7 CH 47.9 CH 49.5 CH
5 214.6 qC 214.9 qC 216.2 qC 217.6 qC
6 48.5 CH 48.3 CH 49.8 CH 51.1 CH
7 80.1 CH 80.1 CH 79.2 CH 79.9 CH
8 131.6 qC 132.0 qC 136.2 qC 139.0 qC
9 132.0 CH 131.7 CH 129.4 CH 129.8 CH
10 46.2 CH 46.1 CH 45.9 CH 46.5 CH
11 211.5 qC 211.7 qC 211.9 qC 212.7 qC
12 42.6 CH2 42.7 CH2 42.5 CH2 44.3 CH2
13 68.9 CH 68.8 CH 69.0 CH 69.3 CH
14 81.6 qC 81.6 qC 81.6 qC 85.0 qC
15 210.8 qC 211.0 qC 211.2 qC 216.5 qC
16 46.9 CH 47.0 CH 46.9 CH 46.4 CH
17 77.8 CH 77.7 CH 77.7 CH 78.4 CH
18 62.7 qC 62.7 qC 62.6 qC 63.9 qC
19 67.1 CH 67.0 CH 67.0 CH 67.4CH
20 31.1 CH 31.1 CH 30.9 CH 32.4 CH
21 129.7 CH 129.4 CH 129.6 CH 131.6 CH
22 125.5 CH 125.5 CH 125.4 CH 126.2 CH
23 13.5 CH3 13.4 CH3 13.3 CH3 13.3 CH3
24 14.6 CH3 14.5 CH3 14.4 CH3 15.3 CH3
25 14.7 CH3 14.5 CH3 15.0 CH3 15.6 CH3
26 10.8 CH3 10.7 CH3 10.2 CH3 10.5 CH3
27 16.3 CH3 16.2 CH3 16.4 CH3 15.7 CH3
28 63.5 CH2 63.5 CH2 63.5 CH2 65.7 CH2
29 63.2 CH2 63.2 CH2 62.8 CH2 64.8 CH2
30 11.1 CH3 11.0 CH3 10.9 CH3 11.5 CH3
31 18.6 CH3 18.4 CH3 18.3 CH3 18.7 CH3
32 60.3 CH3 60.3 CH3 60.3 CH3 60.3 CH3
33 169.5 qC 169.9 qC — —
34 21.6 CH3 21.5 CH3 ——
35 173.5 qC 173.7 qC 173.6 qC —
36 34.2 CH2 34.1 CH2 34.0 CH2 —
37 29.0 CH2 29.0 CH2 29.1 CH2 —
aMeasured in CDCl3. bMeasured in CD3OD.
Then, the cells were observed under a microscope to evaluate
viability of cells whether the fractions were cytotoxic or not.
2.11. MTT Assay. Cultured cells were inoculated to a 96-well
plate with approximate cell density of 1 × 104 cells/mL in
DMEM. After 24h incubation, a series of DMSO solution
of compounds 1–3 were applied to each well and the ﬁnal
concentrations were adjusted as 0, 1, 12.5, 25, 37.5, 50, 62.5,
to 75ng/mL. Cells were incubated for another 24h, and the
media were replaced with 20μLo f5g / m LM T Ts o l u t i o ni n
PBS and incubated for 3.5h. After removal of PBS solution,
an amount of 150μL of DMSO was added to each well and
the cells were reincubated for 15min prior to measurement
withaTecanmicroplatereaderat590nmwithreferenceﬁlter
at 620nm [20, 21].
3. Results and Discussion
As an EtOAc soluble portion of a methanolic extract of the
sponge K09-02 showed potent cytotoxicity against cultured
NBT-T2 cells, the portion was separated repetitively on a
silica gel column followed by Si-60 HPLC aﬀording three
compounds 1, 2,a n d3 as shown in Figure 1.
By inspecting 1Ha n d13C NMR spectra of compound
1 together with database search (Tables 1 and 2,F i g -
ures S1 and S2 (Supplementary Materials available online4 ISRN Pharmaceutics
Table 2: 1H NMR data for compounds 1, 2,a n d3 (J inHz).
Cn o . 115,a 1a 2a 3b
1 ——— —
2 3.96dd (1.0, 7.3) 3.96dd (1.3, 7.5) 3.98dd (1.3, 7.8) 3.76d (2.2)
3 3.64dd (1.3, 7.8) 3.67dd (1.3, 8.0) 3.67dd (1.3, 8.4) 3.81dd (2.2, 9.8)
4 3.12m 3.13dd (8.0, 7.1) 3.10dq (8.4, 7.3) 3.16dq (9.8, 7.1)
5 ——— —
6 3.18dq (10.7, 7.3) 3.22dq (10.7, 6.8) 3.04dq (9.8, 6.8) 3.16dq (10.0, 7.1)
7 5.39d (10.7) 5.41d (10.7) 4.12d (10.0) 4.03d (10.0)
8 ——— —
9 5.60d (9.3) 5.62d (9.6) 5.48d (10.5) 5.33d (9.3)
10 3.38dq (9.3, 6.8) 3.41dq (9.6, 7.0) 3.49dq (10.5, 7.1) 3.36dq (9.3, 6.8)
1 1 ——— —
12 2.66dd (9.8, 16.1) 2.69dd (9.8, 16.1) 2.72dd (9.8, 16.1) 2.75dd (9.5, 17.6)
2.49dd (2.4, 16.1) 2.49dd (2.5, 16.1) 2.51dd (2.0, 16.1) 2.23dd (2.0, 17.6)
13 4.40m 4.42m 4.39dt (2.0, 9.8) 4.44dd (2.9, 9.5)
1 4 ——— —
1 5 ——— —
16 4.02dt (3.9, 10.9) 4.03ddd (3.9, 10.5,
11.5) 4.09dt (3.9, 11.0) 4.08ddd (3.9, 10.8, 11.4)
17 3.12m 3.13m 3.20dd (11.0) 3.20d (10.7)
1 8 ——— —
19 2.56d (9.3) 2.59d (9.3) 2.58d (9.8) 2.62d (9.3)
20 2.44m 2.47m 2.47m 2.48m
21 5.23dt (1.5, 10.7) 5.25ddd (0.7, 10.2,
10.9) 5.24dt (1.5, 10.5) 5.31m
22 5.48dq (10.7, 6.8) 5.51dq (10.9, 6.8) 5.49dq (10.5, 6.8) 5.51dq (10.7, 6.8)
23 1.59dd (1.5, 6.8) 1.62dd (1.2, 6.8) 1.62dd (1.5, 6.8) 1.62dd (1.7, 6.8)
24 1.18d (6.8) 1.21d (7.1) 1.21d (7.3) 1.23d (7.1)
25 1.13d (7.3) 1.16d (6.8) 1.28d (6.8) 1.26d (7.1)
26 1.54brd (1.0) 1.59d (0.8) 1.63s 1.65d (1.5)
27 1.07d (6.8) 1.09d (7.0) 1.10d (7.1) 1.03d (6.8)
28 4.44d (11.7) 4.46d (11.5) 4.45d (11.5) 3.75d (10.5)
4.19d (11.7) 4.22d (11.5) 4.21d (11.5) 3.76d (10.5)
29 4.17dd (3.7, 9.8) 4.20dd (3.7, 10.2) 4.24dd (3.0, 9.5) 4.35dd (3.9, 10.5)
4.10dd (10.2, 10.9) 4.12dd (10.2, 11.2) 4.08m 3.91dd (10.5, 11.4)
30 1.38s 1.42s 1.42s 1.35s
31 1.11d (6.4) 1.13d (6.3) 1.14d (6.6) 1.11d (6.6)
32 3.28s 3.31s 3.30s 3.39s
3 3 ——— —
34 2.01s 2.04s — —
3 5 ——— —
36 2.24t (7.6) 2.27t (7.6) 2.27t (11.8)
37 1.53brs 1.59brs 1.25brs
OH-2 2.85d (7.3) 2.92d (7.5) 2.99d (7.8) 2.92d (7.5)
OH-13 — 4.71s
aMeasured in CDCl3. bMeasured in CD3OD.ISRN Pharmaceutics 5
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(1)R 1 = Ac,R2 = CO(CH2)14–16CH3,R3 = H
(2)R 1 = R3 = H,R2 = CO(CH2)14–19CH3
(3)R 1 = R2 = R3 = H
(4)R 1 = R3 = Ac,R2 = CO(CH2)14–16CH3
Figure 1: Structures of compounds (1)–(4).
at doi:10.5402/2011/852619)), we could readily identify that
it is a member of candidaspongiolide, a series of 18-
membered cytotoxic macrolide retaining one of fatty acid
moieties from C14 to C18 at C-28 [15]. HR-ESIMS of our
material exhibited molecular-related ions at m/z 945.55514,
959.57079, 973.58884 [M+Na]+ indicating that compound 1
is candidaspongiolide esteriﬁed with the homologs of three
saturated fatty acids (palmitic, margaric, and stearic acids).
Compound 2 was obtained as a colorless glass with [α]
25
D
+72. After elucidation of its 1Ha n d13CN M Rs p e c t r a ,
compound 2 was found to be an analog of 1.H o w e v e r ,
the 13C NMR spectrum showed two carbonyl carbons at δC
171.3q (C-1) and 173.1 (C-35) instead of three in 1 (Table 1,
Figure S3). As the signals for an acetoxy group (δH 2.04s,
δC 21.5q) in 1 are missing in 2, it was suggested that 2 is
a deacetyl derivative of 1. The lack of the acetyl group is
in a good agreement with 1H NMR spectrum and COSY
analysis showing that H-7 proton signal (δH 4.12d, J =
10.0Hz) in 2 shifted to higher ﬁeld than that (δH 5.41d, J
= 10.7Hz) in 1 (Table 2). HR-ESIMS of 2 showed a series
of sodiated ions [M+Na]+ at m/z 903.54964, 917.56023,
931.57576, 945.60036, and 959.61056 corresponding to the
presence of C16 to C20 esters. For structural conﬁrmation,
compound 2 was acetylated to give tetraacetate 4,w h i c h
showed signals identical with 4 obtained from 1( Figure S4).
Compound 4 exhibited four acetyl signals at δH 2.22s, 2.10s,
2.09s, and 2.02s and molecular-related ions corresponding
t om a c r o l i d ee s t e r sw i t hC 16 to C18 fatty acids.
Compound 3 was isolated as a yellowish glass with [α]
25
D
+97. Its molecular formula was established as C32H50O13
by observing a molecular-related ion at m/z 665.31522
[M+Na]+ in HR-ESIMS. 1Ha n d13CN M Rs p e c t r a( T a b l e s
1 and 2, Figures S5 and S6) revealed that compound 3 has
a similar macrolide structure to that of compound 1 except
for the lack of a fatty acid ester moiety and an acetate found
in 1. Higher ﬁeld chemical shifts observed for H-7 (δH 4.03)
and H-28 (δH 3.75) indicated that 3 is devoid of acyl groups.
Close similarity of 1Ha n d13CN M Rd a t ao f3 to 1 (Table 2)
indicated that the macrolide core structure of compound3is
identical to compound 1.
All of natural compounds 1–3 exhibited potent cyto-
toxicity, IC50 37, 4.7, and 19ng/mL, against NBT-T2 cells.
T h er e s u l ti sn o ti ng o o da g r e e m e n tw i t ht h o s er e p o r t e d
by Meragelman and coworkers, that is, candidaspongiolide
(1) showed stronger growth inhibition (GI5014ng/mL) than
the core compound (42ng/mL) [15]. Additionally Paul et
al. paperd the importance of a linear carbon chain on the
cytotoxicity in the case of amphidinol [22]. The diﬀerence
may be explained either by the number of cell lines or by
diﬀerent sensitivity of NBT-T2 cells.
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